{"meta":{"query_hash":"a6c1e7626157","filters":{"venue":"Cardiology and Therapy"},"cohort_total":19,"direct_labels_cover":0,"predictions_cover":19,"exported":19,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a6c1e7626157","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cardiology+and+Therapy"},"results":[{"id":"W2133616084","doi":"10.1007/s40119-013-0019-y","title":"Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants","year":2013,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Rivaroxaban; Apixaban; Atrial fibrillation; Dabigatran; Warfarin; Stroke (engine); Contraindication; Intensive care medicine; Risk factor; Internal medicine; Cardiology","score_opus":0.0366053928921816,"score_gpt":0.29035098516621954,"score_spread":0.2537455922740379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133616084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986877,0.00033877336,0.00007450429,0.00009405217,0.00008221494,0.0004962055,0.0000020234215,0.000013668555,0.00021088308],"genre_scores_gemma":[0.9991559,0.00018637284,0.0002796091,0.00003325649,0.00026037503,5.6715203e-7,0.0000374117,0.000007696783,0.00003884755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945706,0.00004351119,0.00017465887,0.00012991743,0.000090455134,0.0001043692],"domain_scores_gemma":[0.9996994,0.000048603266,0.00007006165,0.00010397586,0.000050207622,0.000027744147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010084025,0.000078714016,0.0003547853,0.00009444413,0.00002163938,0.0000059887657,0.000020944319,0.000080046106,0.000025675266],"category_scores_gemma":[0.000018034401,0.00005968827,0.000065764005,0.00010620027,0.00006283053,0.00008055379,0.000011505283,0.000043630887,0.0000036585814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058787054,0.0000028664617,0.98329407,0.000005325354,0.00012186855,8.440773e-7,0.00008138565,0.00023888038,0.0008774061,0.00010472981,0.000012368302,0.014672383],"study_design_scores_gemma":[0.0065444363,0.00028361342,0.99212664,0.00001291497,0.00002956164,0.0000027772153,0.000032377597,0.00027186263,0.00007099417,0.00010395245,0.00045570097,0.00006518632],"about_ca_topic_score_codex":0.000028481529,"about_ca_topic_score_gemma":8.9150564e-7,"teacher_disagreement_score":0.014607197,"about_ca_system_score_codex":0.000006865421,"about_ca_system_score_gemma":0.000010282794,"threshold_uncertainty_score":0.2434017},"labels":[],"label_agreement":null},{"id":"W2270148934","doi":"10.1007/s40119-016-0056-4","title":"Effect of Frailty and Age on Platelet Aggregation and Response to Aspirin in Older Patients with Atrial Fibrillation: A Pilot Study","year":2016,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Atrial fibrillation; Internal medicine; Platelet; Stroke (engine); Platelet activation; Cardiology","score_opus":0.013529569918235559,"score_gpt":0.26932676952783835,"score_spread":0.2557971996096028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2270148934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968277,0.0019124402,0.00003190331,0.0000616024,0.00003875025,0.0010850289,0.00000958372,0.000011701898,0.00002126164],"genre_scores_gemma":[0.9991533,0.0006486545,0.0000056405543,0.000060634127,0.00008871669,0.000010936474,0.0000063804027,0.000010584202,0.0000151525865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988673,0.00055178296,0.0001257631,0.000243365,0.000104673454,0.00010716705],"domain_scores_gemma":[0.99935085,0.00036143558,0.00003527202,0.00015910437,0.000028397055,0.0000649348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053148885,0.00012710992,0.00045616797,0.00009472578,0.00003786911,0.0000043711657,0.000018458208,0.0000577361,0.000004250644],"category_scores_gemma":[0.000052222626,0.0000703375,0.00005212494,0.00007072175,0.00010757223,0.000035658923,0.000012033777,0.000048632333,8.407709e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08857237,0.000028301272,0.66086257,0.000013744549,0.00039199516,0.000057310775,0.00020411692,0.000007369127,0.0004740927,0.0000042366382,0.000003636281,0.24938028],"study_design_scores_gemma":[0.026346268,0.029858932,0.942178,0.00012465726,0.000057631387,0.000024161307,0.000019364803,5.7347336e-7,0.0007634694,0.000016852293,0.0005206669,0.00008939105],"about_ca_topic_score_codex":0.0000048060665,"about_ca_topic_score_gemma":0.0000016151786,"teacher_disagreement_score":0.28131548,"about_ca_system_score_codex":0.000010345393,"about_ca_system_score_gemma":0.000014333768,"threshold_uncertainty_score":0.286828},"labels":[],"label_agreement":null},{"id":"W2527804880","doi":"10.1007/s40119-016-0071-5","title":"A Prospective, Randomized, Open-Label Study to Evaluate Two Management Strategies for Gastrointestinal Symptoms in Patients Newly on Treatment with Dabigatran","year":2016,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Boehringer Ingelheim","keywords":"Medicine; Dabigatran; Randomized controlled trial; Gastrointestinal bleeding; Intensive care medicine; Prospective cohort study; Internal medicine; Atrial fibrillation; Warfarin","score_opus":0.05798855733968124,"score_gpt":0.3663753129274868,"score_spread":0.3083867555878056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527804880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865067,0.000046642628,0.0016243908,0.00062782585,0.000063149186,0.0093015805,0.000004574474,0.00002278834,0.0018023589],"genre_scores_gemma":[0.9978613,0.00007469251,0.00074689114,0.00014940572,0.00010430756,0.0003857369,0.000006479853,0.000014725825,0.0006564337],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990036,0.00016051676,0.00019987824,0.00034322916,0.0001005038,0.00019230595],"domain_scores_gemma":[0.9994713,0.00017964258,0.000052891555,0.00017967059,0.000059247548,0.000057269677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039783385,0.00018663464,0.0006664422,0.00010955601,0.000061218176,0.000025784617,0.000062687555,0.000016140235,0.0000067874835],"category_scores_gemma":[0.000014191986,0.00008768333,0.000057287667,0.000076241035,0.00006875711,0.000069380025,0.000026539808,0.000026740174,0.0000045482875],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24904291,0.00019514255,0.7089976,0.0000060794573,0.0007850457,0.000020635169,0.00024258082,0.00003266895,0.000030521765,0.0026695635,0.00001640851,0.03796085],"study_design_scores_gemma":[0.62145936,0.018387193,0.35803077,0.00007489318,0.00018169673,0.000005407136,0.00028657005,0.0000107705355,0.000011624417,0.0011844813,0.00025414614,0.0001130924],"about_ca_topic_score_codex":0.000012729649,"about_ca_topic_score_gemma":0.000010043883,"teacher_disagreement_score":0.37241644,"about_ca_system_score_codex":0.000068758876,"about_ca_system_score_gemma":0.000024008255,"threshold_uncertainty_score":0.35756224},"labels":[],"label_agreement":null},{"id":"W2737671506","doi":"10.1007/s40119-017-0094-6","title":"Management and Prevention of Saphenous Vein Graft Failure: A Review","year":2017,"lang":"en","type":"review","venue":"Cardiology and Therapy","topic":"Cardiac and Coronary Surgery Techniques","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Revascularization; Saphenous vein graft; Coronary artery disease; Cardiology; Internal medicine; Internal thoracic artery; Artery; Vein; Bypass grafting; Percutaneous; Percutaneous coronary intervention; Surgery; Medical therapy; Myocardial infarction","score_opus":0.06446204936183224,"score_gpt":0.37131431108049534,"score_spread":0.3068522617186631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737671506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015048916,0.9946579,0.00004700968,0.00007414244,0.000097303346,0.0013943681,0.0000126254745,0.000033172342,0.003668454],"genre_scores_gemma":[0.000102221624,0.9985832,0.00013051467,0.000093097755,0.00010535121,0.00021786595,0.00009271629,0.000020904028,0.00065412524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989045,0.0002479423,0.0003365171,0.00030330618,0.000072793664,0.00013490167],"domain_scores_gemma":[0.99911153,0.000049489445,0.00025199857,0.0005002163,0.000034458237,0.00005232619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005262946,0.00024105477,0.002582892,0.000090851696,0.000056749977,0.0000049310815,0.00007084758,0.00024556107,0.0000166529],"category_scores_gemma":[0.000011321508,0.00017224466,0.0006312503,0.00004612581,0.00017734552,0.000026459897,0.000053852036,0.00018189846,0.0000019547883],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021889242,0.000010527632,0.00006256215,0.022179674,0.0010525048,0.000103554405,0.0000033647384,6.696274e-10,1.5522592e-7,0.00025115916,0.0016843822,0.97463024],"study_design_scores_gemma":[0.00022232963,0.00023365433,0.00056415546,0.026892101,0.0014863358,0.0009582066,0.000002231078,8.501734e-9,3.4425213e-7,0.00035316177,0.96915627,0.00013123258],"about_ca_topic_score_codex":0.000002430911,"about_ca_topic_score_gemma":1.791369e-7,"teacher_disagreement_score":0.974499,"about_ca_system_score_codex":0.000013312439,"about_ca_system_score_gemma":0.00004516657,"threshold_uncertainty_score":0.70239335},"labels":[],"label_agreement":null},{"id":"W2804977753","doi":"10.1007/s40119-018-0110-5","title":"Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris","year":2018,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Trimetazidine; Medicine; Adverse effect; Regimen; Randomized controlled trial; Stable angina; Internal medicine; Angina; Anesthesia; Coronary artery disease; Myocardial infarction","score_opus":0.06926098704122748,"score_gpt":0.3636599594483907,"score_spread":0.29439897240716323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804977753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96823716,0.023722097,0.0011261499,0.00029753434,0.0012556695,0.00091858953,0.00005637669,0.00007904966,0.004307389],"genre_scores_gemma":[0.9863231,0.011215563,0.0002745694,0.00055986055,0.0012843672,0.000048804675,0.00006186781,0.000047606565,0.00018427153],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9952453,0.0014927327,0.0011146641,0.0009772494,0.00036552502,0.0008045305],"domain_scores_gemma":[0.9969338,0.00070424925,0.00020596459,0.0012732919,0.00037695674,0.00050569494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039452957,0.00043539068,0.0022586628,0.00024382137,0.00017971576,0.000015245995,0.00022973162,0.0006203802,0.00015852127],"category_scores_gemma":[0.00068210176,0.00036409526,0.00079711527,0.00065072876,0.00082975754,0.00018253435,0.00008398323,0.0008144861,0.00003400287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07415989,0.0026047584,0.31084833,0.00076138065,0.008116258,0.0009889042,0.0019840428,0.000358779,0.024190227,0.0017331961,0.0060705952,0.56818366],"study_design_scores_gemma":[0.06755195,0.011073723,0.82347184,0.000113027614,0.0011793211,0.00022094935,0.0006892882,0.0013736153,0.008822059,0.0005469111,0.08382297,0.0011343264],"about_ca_topic_score_codex":0.0006349044,"about_ca_topic_score_gemma":0.000020827245,"teacher_disagreement_score":0.5670493,"about_ca_system_score_codex":0.000118430464,"about_ca_system_score_gemma":0.00071735634,"threshold_uncertainty_score":0.9998811},"labels":[],"label_agreement":null},{"id":"W2917360774","doi":"10.1007/s40119-019-0128-3","title":"Effectiveness of Long-acting Trimetazidine in Different Clinical Situations in Patients with Stable Angina Pectoris: Findings from ODA Trial","year":2019,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Servier","keywords":"Medicine; Tolerability; Trimetazidine; Angina; Internal medicine; Observational study; Canadian Cardiovascular Society; Randomized controlled trial; Cardiology; Adverse effect; Myocardial infarction","score_opus":0.024319566678029966,"score_gpt":0.31295013783528536,"score_spread":0.2886305711572554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917360774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973663,0.0010296197,0.000120847275,0.000021982958,0.00026893054,0.0010842829,0.000008746301,0.000007951373,0.00009131119],"genre_scores_gemma":[0.9992214,0.00053474936,0.000015252517,0.000026403888,0.00010729566,0.000024124298,0.000052786567,0.000010573808,0.000007416325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844784,0.0007202028,0.00028820944,0.00025599528,0.00010877591,0.00017897441],"domain_scores_gemma":[0.99910897,0.00053300685,0.00004681502,0.00020703937,0.000050229475,0.00005392968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011218182,0.00011269963,0.00094761205,0.000094733856,0.000020831958,0.0000029305568,0.0000297608,0.0001564102,0.000017284146],"category_scores_gemma":[0.00006443656,0.000076245924,0.00013923735,0.00013929198,0.00004626245,0.000041774594,0.000011129121,0.00025053392,0.0000025481672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023165388,0.00015339782,0.97138274,0.000039402617,0.00031612878,0.000010926266,0.00009864625,0.000009898093,0.00021415252,0.000006410567,0.0000021740875,0.0046007587],"study_design_scores_gemma":[0.06536946,0.0017683913,0.9321243,0.00010877576,0.000043615597,0.0000017040419,0.000038340844,0.000005185753,0.0003758289,0.000029070397,0.000066000226,0.00006933173],"about_ca_topic_score_codex":0.00010433816,"about_ca_topic_score_gemma":0.000007158607,"teacher_disagreement_score":0.04220407,"about_ca_system_score_codex":0.000037573707,"about_ca_system_score_gemma":0.00008690071,"threshold_uncertainty_score":0.31092185},"labels":[],"label_agreement":null},{"id":"W2968142039","doi":"10.1007/s40119-019-00145-7","title":"Effectiveness and Impact on Adherence of a New Fixed-Dose Combination of Ivabradine and Metoprolol in a Wide Range of Stable Angina Patients in Real-Life Practice","year":2019,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Servier","keywords":"Medicine; Ivabradine; Tolerability; Metoprolol; Angina; Internal medicine; Cardiology; Myocardial infarction; Canadian Cardiovascular Society; Coronary artery disease; Heart rate; Adverse effect; Blood pressure","score_opus":0.017177069438999007,"score_gpt":0.3181083266908605,"score_spread":0.3009312572518615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968142039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500763,0.0039774263,0.000015052498,0.000049944225,0.000029184006,0.0007276177,0.0000057703915,0.0000024899452,0.00018485382],"genre_scores_gemma":[0.99120635,0.008684833,0.000017210154,0.000059186215,0.0000070286146,0.000008976219,0.0000057217912,0.000005816369,0.0000049042224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990227,0.00043815104,0.00018756524,0.00015415686,0.00008555795,0.00011183188],"domain_scores_gemma":[0.9992289,0.00041087536,0.00008507698,0.00014112088,0.00007704688,0.000057003625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009688723,0.000084895895,0.00066099147,0.000118309035,0.000007729008,0.0000010856542,0.000017751754,0.00010307383,0.0000029416976],"category_scores_gemma":[0.00015917541,0.00006383106,0.000051903422,0.00013954334,0.000060314287,0.00007027488,0.000009575588,0.00010770797,2.2023352e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039145346,0.00010347256,0.9816796,0.00027435517,0.00018600111,0.0000054080783,0.0005660491,0.000013954939,0.0020750698,0.00008908658,0.0000073462966,0.011085084],"study_design_scores_gemma":[0.009676117,0.003318565,0.98529154,0.00015934781,0.000030381074,0.000012276075,0.00009577745,0.000025213216,0.0012067521,0.000096922064,0.000041550484,0.000045556746],"about_ca_topic_score_codex":0.0014883906,"about_ca_topic_score_gemma":0.0000073061274,"teacher_disagreement_score":0.011039527,"about_ca_system_score_codex":0.000018566758,"about_ca_system_score_gemma":0.00010714678,"threshold_uncertainty_score":0.2602955},"labels":[],"label_agreement":null},{"id":"W3026117329","doi":"10.1007/s40119-020-00174-7","title":"Effectiveness of Trimetazidine in Patients with Stable Angina Pectoris of Various Durations: Results from ODA","year":2020,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Servier","keywords":"Trimetazidine; Medicine; Stable angina; Angina; Cardiology; Internal medicine; Coronary artery disease; Myocardial infarction","score_opus":0.01200293812737145,"score_gpt":0.22891049285965775,"score_spread":0.21690755473228632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026117329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703544,0.0019511943,0.00022888214,0.000052488536,0.000043536988,0.00036341834,0.00007184748,0.0000093275485,0.00024385362],"genre_scores_gemma":[0.9993538,0.00035351727,0.000109655695,0.00004384023,0.00004328629,0.000008862933,0.00007536397,0.0000076089277,0.0000040527716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993258,0.0001973564,0.00016404213,0.00016102257,0.0000641877,0.00008756099],"domain_scores_gemma":[0.9992427,0.00046228402,0.00006368483,0.00012209489,0.00007176553,0.000037418802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019926771,0.000081276194,0.0004902735,0.000049845137,0.000012698873,0.0000010139902,0.000028443425,0.00007040825,0.000004104467],"category_scores_gemma":[0.00012634389,0.00005623939,0.000040130737,0.00017291059,0.00006054157,0.00002843529,0.000007676662,0.00008641961,7.5293514e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026828598,0.0001181256,0.9392297,0.00010820024,0.0005110259,0.000025940753,0.00051061384,0.000082409744,0.030329822,0.000057044923,0.00003855948,0.0021599068],"study_design_scores_gemma":[0.015306123,0.001997972,0.9579083,0.000065659166,0.00005667151,0.0000017898092,0.000024813722,0.000013515114,0.02429521,0.00011326641,0.00015680594,0.000059892674],"about_ca_topic_score_codex":0.000114628885,"about_ca_topic_score_gemma":7.0523544e-7,"teacher_disagreement_score":0.018678525,"about_ca_system_score_codex":0.000008292384,"about_ca_system_score_gemma":0.000035281664,"threshold_uncertainty_score":0.22933757},"labels":[],"label_agreement":null},{"id":"W3107892918","doi":"10.1007/s40119-020-00202-6","title":"Trimetazidine and Bisoprolol to Treat Angina in Symptomatic Patients: Post Hoc Analysis From the CHOICE-2 Study","year":2020,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Servier","keywords":"Medicine; Bisoprolol; Trimetazidine; Angina; Internal medicine; Cardiology; Post-hoc analysis; Anesthesia; Heart failure; Myocardial infarction","score_opus":0.02200588959214892,"score_gpt":0.28335997060801793,"score_spread":0.261354081015869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107892918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98367447,0.011082004,0.000035892306,0.004146912,0.000030895786,0.0009135335,0.000019057634,0.000021951095,0.00007530044],"genre_scores_gemma":[0.9900184,0.0020101457,0.000017206072,0.0076668886,0.00018068419,0.00004640043,0.00004117734,0.0000104015835,0.000008640558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987511,0.0004221619,0.0002002081,0.00032989203,0.00010725889,0.00018936528],"domain_scores_gemma":[0.99930114,0.00017401377,0.00002419209,0.00027131618,0.000064979446,0.00016438367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003379591,0.00014138813,0.000769533,0.00009379567,0.00007662163,0.000011084062,0.000051519735,0.0000840673,0.00001442212],"category_scores_gemma":[0.00009719686,0.00008457219,0.00016590634,0.000515126,0.00004774024,0.000029489218,0.000026493155,0.00014993157,0.000008285986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048643732,0.000062900646,0.9571762,0.000008683782,0.001816599,0.000035416087,0.0024869975,0.000008920424,0.00012857655,0.0000021449052,0.00014075212,0.037646383],"study_design_scores_gemma":[0.0042651393,0.0023309852,0.98744905,0.0000057865577,0.00072072,0.0000055315327,0.00059647794,0.000025469779,0.000017277107,0.000008403885,0.00449116,0.00008397599],"about_ca_topic_score_codex":0.00031487277,"about_ca_topic_score_gemma":0.00003934304,"teacher_disagreement_score":0.037562404,"about_ca_system_score_codex":0.000013502214,"about_ca_system_score_gemma":0.000031794803,"threshold_uncertainty_score":0.34487537},"labels":[],"label_agreement":null},{"id":"W4280490176","doi":"10.1007/s40119-022-00265-7","title":"Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)","year":2022,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Colorado Denver; School of Medicine, Vanderbilt University; School of Medicine, Stanford University; Samsung; Aarhus Universitetshospital; University of Alberta; University of Utah; Universitair Medisch Centrum Groningen; Pfizer; Northwestern University; Sungkyunkwan University; Vanderbilt University; Yale University; Aarhus Universitet","keywords":"Transthyretin; Amyloidosis; Medicine; Internal medicine","score_opus":0.02476310667573326,"score_gpt":0.26778167958781246,"score_spread":0.2430185729120792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280490176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870081,0.010419882,0.00012695012,0.0011230333,0.0002457182,0.0004386045,0.0005382204,0.00003496546,0.000064506836],"genre_scores_gemma":[0.9864532,0.0101235695,0.000043367585,0.0015740893,0.00010976556,0.00034803688,0.0012058418,0.00004249043,0.00009968164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99512327,0.002653702,0.00047103319,0.0009982613,0.00024081976,0.00051291997],"domain_scores_gemma":[0.9983618,0.0004882244,0.00014552483,0.0008254392,0.000052407187,0.0001265778],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010248785,0.00047854934,0.0010582826,0.00015898577,0.00044571672,0.000045252327,0.0006606513,0.00028848177,0.00018803791],"category_scores_gemma":[0.00005406636,0.0003490679,0.0004600242,0.00057564775,0.00036665032,0.000012658808,0.00010432718,0.00036307587,0.0000035736007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051778974,0.00016349276,0.98697853,0.000001575419,0.002738371,0.0000143273965,0.0007799543,0.00028453342,0.003965279,0.000021107135,0.00016052723,0.0043745353],"study_design_scores_gemma":[0.0019062636,0.00066933135,0.9914738,0.0000023190735,0.00034186323,0.00000973883,0.0011618751,0.00004120414,0.001911262,0.00009771088,0.0019656827,0.0004189696],"about_ca_topic_score_codex":0.0017868612,"about_ca_topic_score_gemma":0.0014463651,"teacher_disagreement_score":0.004495272,"about_ca_system_score_codex":0.000037668735,"about_ca_system_score_gemma":0.00007239563,"threshold_uncertainty_score":0.9998961},"labels":[],"label_agreement":null},{"id":"W4311500443","doi":"10.1007/s40119-022-00289-z","title":"Hyperkalemia: Prevalence, Predictors and Emerging Treatments","year":2022,"lang":"en","type":"review","venue":"Cardiology and Therapy","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Horizon Health Network; Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Hyperkalemia; Medicine; Kidney disease; Intensive care medicine; Epidemiology; Disease; Adverse effect; Diabetes mellitus; Heart failure; Internal medicine; Endocrinology","score_opus":0.03820853109615856,"score_gpt":0.3212420952053226,"score_spread":0.283033564109164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311500443","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00165011,0.99257445,0.0000013541829,0.000028242841,0.00036471162,0.0006391992,0.000038333827,0.000048997616,0.0046545775],"genre_scores_gemma":[0.000112435075,0.99785393,0.000006802151,0.00008167251,0.00014074765,0.00016670705,0.00013457371,0.000034155626,0.0014689999],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988421,0.00021663934,0.000233586,0.00040223467,0.00008085571,0.00022455407],"domain_scores_gemma":[0.9994514,0.000119247976,0.00009178821,0.00022197563,0.000008283095,0.00010731381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014621214,0.00029890714,0.0013627971,0.00013876855,0.00016315244,0.0000050124945,0.00005871558,0.00045530815,0.00015575472],"category_scores_gemma":[0.000012734511,0.0001954133,0.00027789111,0.00011272286,0.00019576734,0.00002096239,0.00003400532,0.0005015437,0.0000044356057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034088243,0.000022123566,0.0026707212,0.0025388922,0.0022010342,0.0001193509,0.00009444138,1.2896858e-7,3.7593514e-7,0.00001890592,0.00039555944,0.9919044],"study_design_scores_gemma":[0.0010822308,0.00034631396,0.0006114302,0.00070236763,0.001858383,0.0012350181,0.000030368574,5.3797174e-7,7.384784e-8,0.000030350275,0.99394226,0.0001606878],"about_ca_topic_score_codex":0.0000019589882,"about_ca_topic_score_gemma":3.9797445e-8,"teacher_disagreement_score":0.99354666,"about_ca_system_score_codex":0.000030724186,"about_ca_system_score_gemma":0.000091378206,"threshold_uncertainty_score":0.7968723},"labels":[],"label_agreement":null},{"id":"W4317423838","doi":"10.1007/s40119-022-00300-7","title":"Guideline LDL-C Threshold Achievement in Acute Myocardial Infarction Patients: A Real-World Evidence Study Demonstrating the Impact of Treatment Intensification with PCSK9i","year":2023,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary; Amgen (Canada)","funders":"Amgen Canada; Government of Alberta; Alberta Precision Laboratories; Amgen","keywords":"Ezetimibe; Medicine; Statin; Internal medicine; Myocardial infarction; Cohort; Retrospective cohort study; Evolocumab; Guideline; Cardiology; Cholesterol; Lipoprotein; Pathology","score_opus":0.04897385325442376,"score_gpt":0.3544296291000235,"score_spread":0.30545577584559974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317423838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672717,0.0006201647,0.00006750422,0.00058534404,0.00006339772,0.0017600476,0.0000061327673,0.000030061683,0.00014018962],"genre_scores_gemma":[0.9924527,0.006970455,0.000029179299,0.0001267101,0.00014189217,0.00020871699,0.00004283208,0.000012617695,0.000014912625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987605,0.0002539709,0.00035453975,0.0002664087,0.00016542905,0.00019913762],"domain_scores_gemma":[0.9991775,0.00007076515,0.00010619793,0.00042138848,0.00017341088,0.000050722338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010487476,0.0001561082,0.00050731277,0.00013968669,0.00009297779,0.000007147316,0.00004859823,0.00005834339,0.0000022543193],"category_scores_gemma":[0.00002800147,0.000078811514,0.00018459423,0.0004139492,0.00009688859,0.000056012585,0.000018944536,0.00013718763,0.0000012694505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011632883,0.000118919656,0.95345545,0.000005510592,0.0019253198,0.00001793503,0.0007985527,0.0004941938,0.0004799897,0.000020066896,0.000074092764,0.041446675],"study_design_scores_gemma":[0.003304558,0.0060556713,0.9892453,0.00004946563,0.00016851969,0.000021621614,0.00067727204,0.00017908456,0.000075742275,0.000032478427,0.00011757882,0.000072711766],"about_ca_topic_score_codex":0.0022111183,"about_ca_topic_score_gemma":0.00013020527,"teacher_disagreement_score":0.041373964,"about_ca_system_score_codex":0.00016221359,"about_ca_system_score_gemma":0.00015810678,"threshold_uncertainty_score":0.33425644},"labels":[],"label_agreement":null},{"id":"W4324304841","doi":"10.1007/s40119-023-00310-z","title":"Correction to: Guideline LDL-C Threshold Achievement in Acute Myocardial Infarction Patients: A Real-World Evidence Study Demonstrating the Impact of Treatment Intensification with PCSK9i","year":2023,"lang":"en","type":"erratum","venue":"Cardiology and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary; Amgen (Canada)","funders":"","keywords":"Medicine; Guideline; Myocardial infarction; Intensive care medicine; Internal medicine; Cardiology; Pathology","score_opus":0.04057259202886799,"score_gpt":0.3490907356350811,"score_spread":0.3085181436062131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324304841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98380476,0.0021959078,0.00018894914,0.00075547583,0.0060175313,0.005946357,0.000034372337,0.000068790694,0.0009878377],"genre_scores_gemma":[0.97426075,0.021734307,0.000027037822,0.00023465768,0.0012640754,0.00067696057,0.0003657728,0.000053215037,0.0013832363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977283,0.00044545057,0.00065203593,0.0005580649,0.00031617383,0.00030000554],"domain_scores_gemma":[0.9983491,0.00011804635,0.00028357812,0.0007298512,0.00042246524,0.00009697692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012907847,0.00036843648,0.0011623378,0.00031998055,0.00013951633,0.000016649616,0.00009204555,0.00021567401,0.0000030423605],"category_scores_gemma":[0.000099385885,0.0002008207,0.00038802755,0.0005736006,0.00010313745,0.000058776794,0.000036861144,0.0005836738,0.0000022683553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049184114,0.0004365112,0.796558,0.000043488428,0.010647729,0.00005758659,0.0019379725,0.0012037242,0.00013894938,0.000006850099,0.07230761,0.11174317],"study_design_scores_gemma":[0.0028352907,0.014561762,0.9773266,0.00046426058,0.0006187426,0.000045278128,0.0006562414,0.00018279895,0.000015128171,0.000011518188,0.0030845804,0.00019781463],"about_ca_topic_score_codex":0.00959817,"about_ca_topic_score_gemma":0.0012764744,"teacher_disagreement_score":0.18076858,"about_ca_system_score_codex":0.0006215342,"about_ca_system_score_gemma":0.0005891794,"threshold_uncertainty_score":0.996997},"labels":[],"label_agreement":null},{"id":"W4387429392","doi":"10.1007/s40119-023-00334-5","title":"Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study","year":2023,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Université Laval; Centre hospitalier universitaire de Québec; Amgen (Canada)","funders":"Amgen Canada; Amgen","keywords":"Evolocumab; Medicine; Hyperlipidemia; Internal medicine; Diabetes mellitus; Endocrinology; Total cholesterol; Cholesterol","score_opus":0.017380496165767822,"score_gpt":0.2911795570283895,"score_spread":0.2737990608626217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387429392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707144,0.0014593904,0.000015603728,0.00019516288,0.0001213828,0.0010088035,0.000022719078,0.00005455394,0.000050949155],"genre_scores_gemma":[0.9953391,0.0033940438,0.000016446518,0.00063876144,0.00022755178,0.000109662644,0.00014220476,0.000019535024,0.000112685746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981772,0.00050441717,0.00027100687,0.0004567125,0.00028647453,0.0003042263],"domain_scores_gemma":[0.9985561,0.00036846538,0.00006831837,0.00078731275,0.00013270947,0.00008710598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076949946,0.00019339997,0.00090760156,0.00014681781,0.00023297885,0.000024937874,0.000105445244,0.0001308923,0.000008568272],"category_scores_gemma":[0.0000552203,0.0001046212,0.00019282693,0.0010770774,0.00019883763,0.00008283376,0.000051183997,0.0002933327,0.000010753628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010383882,0.00005011913,0.9847308,0.0000051926568,0.0039771204,0.00006872936,0.006405005,0.00009625775,0.0000020725608,0.000023226616,0.00015026728,0.0034528165],"study_design_scores_gemma":[0.005556429,0.0005944293,0.9863366,0.000017409642,0.0003817453,0.0000010871165,0.001990308,0.0000311897,0.000004431313,0.00009046534,0.0048740515,0.000121836645],"about_ca_topic_score_codex":0.010124477,"about_ca_topic_score_gemma":0.004567833,"teacher_disagreement_score":0.005556643,"about_ca_system_score_codex":0.00006476283,"about_ca_system_score_gemma":0.000076144606,"threshold_uncertainty_score":0.9964672},"labels":[],"label_agreement":null},{"id":"W4391324086","doi":"10.1007/s40119-024-00349-6","title":"Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study","year":2024,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital; Amgen (Canada)","funders":"Amgen Canada; Alberta Precision Laboratories; Government of Alberta","keywords":"Medicine; Internal medicine; Myocardial infarction; Ezetimibe; Unstable angina; Cardiology; Statin; Population; Stroke (engine); Guideline; Acute coronary syndrome; Coronary artery disease; Diabetes mellitus; Endocrinology","score_opus":0.03969821616150351,"score_gpt":0.29880981830710146,"score_spread":0.2591116021455979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391324086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96095246,0.034763623,0.00032292368,0.000096397125,0.00041344555,0.0030837713,0.00010694697,0.00006811441,0.0001922894],"genre_scores_gemma":[0.98704934,0.011802797,0.0001387619,0.000073442585,0.00036710422,0.00034272735,0.00013512537,0.00006268249,0.000028029997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964001,0.00072751153,0.0006575574,0.0009235095,0.00088530424,0.0004059816],"domain_scores_gemma":[0.99802667,0.000069573915,0.00009538694,0.0012408681,0.00034510717,0.00022241591],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025763966,0.0003880608,0.0016268932,0.0002982027,0.00011117979,0.000012268431,0.00012691444,0.00013635687,0.000016992111],"category_scores_gemma":[0.00007407687,0.00028023554,0.0013283081,0.0006397617,0.0001177831,0.00011411803,0.000059980277,0.0005266058,0.0000035050907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009989325,0.00033819713,0.9603925,0.00011677395,0.017518902,0.00011914179,0.0003157825,0.0008348621,0.000002904425,0.00012032671,0.00006508398,0.019176587],"study_design_scores_gemma":[0.007480405,0.001107406,0.98454267,0.00023338135,0.0016914988,0.000011141097,0.00010712202,0.00015477258,0.000007188715,0.00048348267,0.003909073,0.00027189017],"about_ca_topic_score_codex":0.0006588142,"about_ca_topic_score_gemma":0.000041770545,"teacher_disagreement_score":0.02609684,"about_ca_system_score_codex":0.0002206751,"about_ca_system_score_gemma":0.00027751207,"threshold_uncertainty_score":0.99996495},"labels":[],"label_agreement":null},{"id":"W4408608338","doi":"10.1007/s40119-025-00402-y","title":"Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis Care","year":2025,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"AstraZeneca","keywords":"Medicine; Amyloidosis; AL amyloidosis; Intensive care medicine; Internal medicine; Immunology","score_opus":0.039926299408125615,"score_gpt":0.35001889310870066,"score_spread":0.31009259370057507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408608338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750468,0.022516416,0.0004526743,0.0004252645,0.00009866297,0.001184193,0.000028245897,0.000023842184,0.0002238655],"genre_scores_gemma":[0.97060645,0.025988715,0.0018153641,0.0006148244,0.00006233623,0.00073971937,0.000058273872,0.000017282238,0.00009705907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983574,0.00042272624,0.00028145107,0.0005959844,0.0000657137,0.00027669518],"domain_scores_gemma":[0.99915904,0.00019656915,0.000079947924,0.00037426554,0.00010908672,0.00008111246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030266383,0.00023424985,0.00047273634,0.00020401063,0.00011034957,0.000017801944,0.00016948274,0.0002346625,0.000005069674],"category_scores_gemma":[0.00008445455,0.00021437347,0.00007785498,0.0002298485,0.00027375005,0.000014717243,0.00010019802,0.00009767925,7.55358e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070152845,0.00010249059,0.8616859,0.000054704837,0.00030583644,0.000012982413,0.00068674877,0.00039010405,0.09196789,0.00020311955,0.00039245145,0.043496292],"study_design_scores_gemma":[0.0022849035,0.0019896969,0.8499604,0.0001910067,0.00010880618,0.000017737188,0.0010400792,0.000028305754,0.13874836,0.00017653637,0.0050187805,0.00043539787],"about_ca_topic_score_codex":0.000113731985,"about_ca_topic_score_gemma":0.00021599856,"teacher_disagreement_score":0.04678048,"about_ca_system_score_codex":0.000028358496,"about_ca_system_score_gemma":0.00008539245,"threshold_uncertainty_score":0.8741896},"labels":[],"label_agreement":null},{"id":"W4409924070","doi":"10.1007/s40119-025-00405-9","title":"Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study","year":2025,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Trimetazidine; Observational study; Internal medicine; Acute coronary syndrome; Cardiology; Adverse effect; Myocardial infarction","score_opus":0.017952775489749093,"score_gpt":0.279311719400205,"score_spread":0.2613589439104559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409924070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458694,0.0041104974,0.000040809915,0.00008491179,0.00010714252,0.001014935,0.000004398229,0.0000071856252,0.00004318065],"genre_scores_gemma":[0.9994826,0.00036535767,0.00000333464,0.00006479902,0.000009437217,0.000045770616,0.000011974365,0.000004729928,0.0000120145605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989653,0.0004447643,0.00017503131,0.0002266722,0.00009083184,0.00009740054],"domain_scores_gemma":[0.99941826,0.0002709807,0.000031452724,0.00020484405,0.000055081728,0.000019405441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006729598,0.000101585625,0.00052104593,0.0000806082,0.000041822936,0.0000026621967,0.00003586117,0.00007238066,0.000004249111],"category_scores_gemma":[0.000032437973,0.00005916673,0.00006393875,0.00022572259,0.00017292937,0.000035648372,0.000021481637,0.00017144896,1.6338953e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019987863,0.0001756914,0.99021614,0.000038314654,0.00051545445,0.0000138865735,0.0000931262,0.0000869365,0.000064620326,0.00005454496,0.0000021318233,0.0067403647],"study_design_scores_gemma":[0.01122178,0.0012617556,0.9870309,0.000052917403,0.00005784415,0.000021380674,0.000070587346,0.000008138952,0.000030369958,0.00005823756,0.00013241402,0.000053655127],"about_ca_topic_score_codex":0.00006166753,"about_ca_topic_score_gemma":0.000022438266,"teacher_disagreement_score":0.009222994,"about_ca_system_score_codex":0.000040171602,"about_ca_system_score_gemma":0.00009237298,"threshold_uncertainty_score":0.24127492},"labels":[],"label_agreement":null},{"id":"W4410634442","doi":"10.1007/s40119-025-00417-5","title":"Correction: Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis Care","year":2025,"lang":"en","type":"erratum","venue":"Cardiology and Therapy","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Amyloidosis; Medicine; Intensive care medicine; Pathology","score_opus":0.037341238063662574,"score_gpt":0.33834865369191747,"score_spread":0.3010074156282549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410634442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5334075,0.41968358,0.0014700164,0.0019318584,0.021940056,0.011945751,0.0007963299,0.0002694769,0.008555406],"genre_scores_gemma":[0.5738821,0.3963856,0.00222097,0.00151765,0.0016461248,0.004108392,0.002041483,0.00013628675,0.018061405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970705,0.0007622347,0.00048699294,0.0011251037,0.00013609041,0.0004191101],"domain_scores_gemma":[0.9984495,0.0003011703,0.00023406002,0.0006402211,0.0002393485,0.00013567253],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037949858,0.0005268829,0.0010554969,0.00038618335,0.00017813331,0.00003473068,0.00029680994,0.00093935855,0.000012450956],"category_scores_gemma":[0.0001737244,0.0005031145,0.00017686536,0.00032085206,0.0003876634,0.000017649274,0.00017247327,0.00040299934,0.0000012145607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027386856,0.00041818176,0.49734515,0.00057377596,0.0022429554,0.00010476411,0.002225547,0.00096490426,0.015317724,0.000076669945,0.34412217,0.13386948],"study_design_scores_gemma":[0.0056018163,0.010476401,0.5700241,0.0026617541,0.0009340001,0.0001809848,0.0028121055,0.00012398647,0.0414085,0.00014155511,0.36279556,0.0028392714],"about_ca_topic_score_codex":0.00024580426,"about_ca_topic_score_gemma":0.0006337172,"teacher_disagreement_score":0.13103022,"about_ca_system_score_codex":0.000073907824,"about_ca_system_score_gemma":0.0003194513,"threshold_uncertainty_score":0.99974203},"labels":[],"label_agreement":null},{"id":"W4412156652","doi":"10.1007/s40119-025-00421-9","title":"Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOS","year":2025,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"VA Greater Los Angeles Healthcare System; School of Medicine, Vanderbilt University; RWTH Aachen University; National Taiwan University; Universitair Medisch Centrum Groningen; National Institute of Diabetes and Digestive and Kidney Diseases; National Taiwan University Hospital; Universiti Malaya; University of Alberta; King Faisal Specialist Hospital and Research Centre; University of Colorado Denver; Universität Heidelberg; Pfizer; Medical Center, University of Pittsburgh; Samsung; Centre Hospitalier Universitaire de Toulouse; University of Pittsburgh; Cleveland Clinic; Sungkyunkwan University; Yale University; Vanderbilt University","keywords":"Medicine; Transthyretin; Internal medicine; Cohort; Amyloidosis; Population; Cohort study; Incidence (geometry); Environmental health","score_opus":0.009742529089259655,"score_gpt":0.24867907800684047,"score_spread":0.23893654891758082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412156652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949677,0.0025752112,0.00040612812,0.000041615112,0.000050424835,0.0005312084,0.00027056047,0.00001865754,0.0011384764],"genre_scores_gemma":[0.9962559,0.001878568,0.0000774748,0.00009811031,0.00003085625,0.00013673547,0.001451683,0.000023480514,0.000047240672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826366,0.00045769048,0.00029848845,0.0006331964,0.000111748166,0.00023521467],"domain_scores_gemma":[0.99908805,0.00007105889,0.00012490002,0.0005295378,0.00011663674,0.00006984088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019740856,0.00030912843,0.0009377759,0.00022272163,0.000057008303,0.000010695189,0.00015934247,0.00020362972,0.0000067583287],"category_scores_gemma":[0.000008956944,0.00022217646,0.00017023152,0.0004649914,0.00029469305,0.000009609004,0.000024937128,0.000098280114,3.6628524e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002836012,0.00016060994,0.98910064,0.000006007898,0.005387684,0.000015549658,0.00006937962,0.00015765164,0.0012209059,0.00004439263,0.00002629738,0.0009748815],"study_design_scores_gemma":[0.0044440087,0.0008620838,0.9878311,0.000015256941,0.00054832565,3.6794535e-7,0.00014698543,0.000007046099,0.005446417,0.000027076947,0.00044107594,0.0002302251],"about_ca_topic_score_codex":0.0018440897,"about_ca_topic_score_gemma":0.0018320752,"teacher_disagreement_score":0.0048393584,"about_ca_system_score_codex":0.000023831657,"about_ca_system_score_gemma":0.00009756992,"threshold_uncertainty_score":0.9060093},"labels":[],"label_agreement":null}]}